UroGen Pharma Ltd. (URGN) has 83 open-market insider trades by 8 insiders since 2017. Over the last six months insiders net sold $3.2M. The most active filer is Mark Schoenberg.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jay Moorin | 10% Owner | — | 1 | $17.0M | 2017-11-28 |
| Mark Schoenberg | — | — | 41 | $4.5M | 2026-09-08 |
| Elizabeth A. Barrett | CEO | — | 6 | $1.6M | 2023-01-31 |
| Jason Drew Smith | CLO | — | 14 | $1.1M | 2026-09-08 |
| Stephen Mullennix | COO | — | 7 | $308K | 2020-04-27 |
| Peter P. Pfreundschuh | CFO | — | 9 | $167K | 2020-10-15 |
| Chris Degnan | CFO | — | 2 | $118K | 2026-10-08 |
| Molly Henderson | CFO | — | 3 | $73K | 2022-01-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Chris Degnan | CFO | Sell | $81K | 2026-10-08 |
| Mark Schoenberg | — | Sell | $37K | 2026-09-08 |
| Jason Drew Smith | CLO | Sell | $65K | 2026-09-08 |
| Mark Schoenberg | — | Sell | $2.9M | 2026-08-20 |
| Mark Schoenberg | — | Sell | $400K | 2026-07-09 |
| Mark Schoenberg | — | Sell | $350K | 2026-06-22 |
Companies that share insiders with URGN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mark Schoenberg | — | Sell | $143K | 2026-06-08 |
| Mark Schoenberg | — | Sell | $300K | 2026-05-08 |
| Jason Drew Smith | CLO | Sell | $147K | 2026-02-03 |
| Mark Schoenberg | — | Sell | $145K | 2026-02-03 |
| Mark Schoenberg | — | Sell | $250K | 2025-11-19 |
| Chris Degnan | CFO | Sell | $37K | 2025-10-08 |
| Mark Schoenberg | Chief Medical Officer | Sell | $17K | 2025-09-08 |
| Jason Drew Smith | General Counsel | Sell | $29K | 2025-09-08 |
| Mark Schoenberg | — | Sell | $177K | 2025-08-11 |